Ronit Simantov's Insider Trades & SAST Disclosures
Ronit Simantov's most recent trade in Tempest Therapeutics Inc was a trade of 16,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ronit Simantov.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Ronit Simantov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Gamida Cell Ltd | Simantov Ronit | CMO & CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 480,319 | 655,896 | - | 0 | Ordinary Shares | |
| Tempest Therapeutics Inc | Ronit Simantov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Gamida Cell Ltd | Ronit Simantov | CMO & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 116,340 | 116,340 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell Ltd | Ronit Simantov | CMO & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 58,100 | 175,577 | - | 0 | Ordinary Shares | |
| Tempest Therapeutics Inc | Ronit Simantov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 3,500 | 3,500 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Ronit Simantov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 6,635 | 6,635 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges